Provided by Tiger Fintech (Singapore) Pte. Ltd.

IRIDEX Corp

1.13
+0.160016.49%
Post-market: 1.09-0.0400-3.54%16:22 EDT
Volume:354.20K
Turnover:402.17K
Market Cap:18.80M
PE:-1.67
High:1.24
Open:1.06
Low:1.05
Close:0.9700
Loading ...

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

GlobeNewswire
·
Yesterday

IRIDEX Corp - Strategic Review Ongoing With Multiple Parties

THOMSON REUTERS
·
14 Jan

IRIDEX Corp - Q4 Revenue Expected Between $12.6 Mln and $12.7 Mln

THOMSON REUTERS
·
14 Jan

IRIDEX Outlook FY Revenue USD 48.6-48.7 Million

THOMSON REUTERS
·
14 Jan

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024

GlobeNewswire
·
14 Jan

Iridex Says Study Confirms MicroPulse Laser Therapy for Glaucoma Management

MT Newswires Live
·
19 Dec 2024

Iridex publishes MicroPulse Transscleral Laser Therapy study

TIPRANKS
·
19 Dec 2024

BRIEF-Iridex Comments On Changing Glaucoma Reimbursement Landscape

Reuters
·
19 Nov 2024

Iridex comments on changing glaucoma reimbursement landscape

TIPRANKS
·
19 Nov 2024

IRIDEX Corp: Encouraged That Transscleral Cyclophotocoagulation Remains Unaffected by Recent Glaucoma Lcd

THOMSON REUTERS
·
19 Nov 2024

IRIDEX Corp: IRIDEX's Cyclo G6 Product Family Is Unaffected by New Reimbursement Limitations

THOMSON REUTERS
·
19 Nov 2024

IRIDEX Comments on Changing Glaucoma Reimbursement Landscape

THOMSON REUTERS
·
19 Nov 2024

Iridex Comments on Changing Glaucoma Reimbursement Landscape

GlobeNewswire
·
19 Nov 2024

3 US Penny Stocks With Market Caps Under $50M To Watch

Simply Wall St.
·
14 Nov 2024

IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ...

GuruFocus.com
·
13 Nov 2024

Iridex Q3 EPS $(0.12) Misses $(0.09) Estimate, Sales $11.58M Miss $12.50M Estimate

Benzinga
·
13 Nov 2024